View in EDS

Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS-Meet-URO 26 Real-World Study.

Saved in:
Bibliographic Details
Title: Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS-Meet-URO 26 Real-World Study.
Authors: Patrikidou A; Department of Medical Oncology and Early Drug Development Department, Gustave Roussy Institute, Villejuif, France., Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit-ISPRO, Florence, Italy., Lee-Ying R; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Nuzzo PV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY., Zarif TE; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., McClure H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Davidsohn M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Eid M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Spinelli GP; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy., Catalano F; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Cremante M; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Fotia G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Rossetti S; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Valenca L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Vauchier C; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Ottanelli C; University of Florence, Florence, Italy., Andrade L; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil., Gennusa V; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Pignata S; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Procopio G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Santini D; Oncology Unit, Umberto I hospital, Rome, Italy., Ravi P; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Heng D; Tom Baker Cancer Centre, Calgary, Alberta, Canada., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), Meldola, Italy., Fizazi K; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.
Corporate Authors: SPARTACUSS Group
Source: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Dec; Vol. 22 (6), pp. 102230. Date of Electronic Publication: 2024 Oct 05.
Publication Type: Journal Article; Comparative Study; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39461026
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS-Meet-URO 26 Real-World Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Patrikidou+A%22">Patrikidou A</searchLink>; Department of Medical Oncology and Early Drug Development Department, Gustave Roussy Institute, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Saieva+C%22">Saieva C</searchLink>; Cancer Risk Factors and Lifestyle Epidemiology Unit-ISPRO, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Lee-Ying+R%22">Lee-Ying R</searchLink>; Tom Baker Cancer Centre, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Nuzzo+PV%22">Nuzzo PV</searchLink>; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY.<br /><searchLink fieldCode="AU" term="%22Zarif+TE%22">Zarif TE</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22McClure+H%22">McClure H</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Davidsohn+M%22">Davidsohn M</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Eid+M%22">Eid M</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Spinelli+GP%22">Spinelli GP</searchLink>; Division of Medical Oncology, Casa della Salute di Aprilia, Latina, Sapienza University of Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Catalano+F%22">Catalano F</searchLink>; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Cremante+M%22">Cremante M</searchLink>; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Fotia+G%22">Fotia G</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Rossetti+S%22">Rossetti S</searchLink>; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Valenca+L%22">Valenca L</searchLink>; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Vauchier+C%22">Vauchier C</searchLink>; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Ottanelli+C%22">Ottanelli C</searchLink>; University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Andrade+L%22">Andrade L</searchLink>; Instituto D'Or de Pesquisa e Ensino, Salvador, Brazil.<br /><searchLink fieldCode="AU" term="%22Gennusa+V%22">Gennusa V</searchLink>; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Mestre+RP%22">Mestre RP</searchLink>; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fornarini+G%22">Fornarini G</searchLink>; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Pignata+S%22">Pignata S</searchLink>; Instituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Procopio+G%22">Procopio G</searchLink>; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Santini+D%22">Santini D</searchLink>; Oncology Unit, Umberto I hospital, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Ravi+P%22">Ravi P</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Sweeney+C%22">Sweeney C</searchLink>; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Heng+D%22">Heng D</searchLink>; Tom Baker Cancer Centre, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22De+Giorgi+U%22">De Giorgi U</searchLink>; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST), Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Fizazi+K%22">Fizazi K</searchLink>; Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Russo+A%22">Russo A</searchLink>; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Francini+E%22">Francini E</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: edoardo.francini@unifi.it.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22SPARTACUSS+Group%22">SPARTACUSS Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101260955%22">Clinical genitourinary cancer</searchLink> [Clin Genitourin Cancer] 2024 Dec; Vol. 22 (6), pp. 102230. <i>Date of Electronic Publication: </i>2024 Oct 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101260955 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215587673%22">15587673 </searchLink><i>NLM ISO Abbreviation: </i>Clin Genitourin Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39461026
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clgc.2024.102230
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102230
    Titles:
      – TitleFull: Docetaxel Versus Androgen-Receptor Signaling Inhibitors (ARSI) as Second-Line Therapy After Failure of First-Line Alternative ARSI for the Elderly ≥ 75 Years Old With Metastatic Castration-Resistant Prostate Cancer (mCRPC): A SPARTACUSS-Meet-URO 26 Real-World Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Patrikidou A
      – PersonEntity:
          Name:
            NameFull: Saieva C
      – PersonEntity:
          Name:
            NameFull: Lee-Ying R
      – PersonEntity:
          Name:
            NameFull: Nuzzo PV
      – PersonEntity:
          Name:
            NameFull: Zarif TE
      – PersonEntity:
          Name:
            NameFull: McClure H
      – PersonEntity:
          Name:
            NameFull: Davidsohn M
      – PersonEntity:
          Name:
            NameFull: Eid M
      – PersonEntity:
          Name:
            NameFull: Spinelli GP
      – PersonEntity:
          Name:
            NameFull: Catalano F
      – PersonEntity:
          Name:
            NameFull: Cremante M
      – PersonEntity:
          Name:
            NameFull: Fotia G
      – PersonEntity:
          Name:
            NameFull: Rossetti S
      – PersonEntity:
          Name:
            NameFull: Valenca L
      – PersonEntity:
          Name:
            NameFull: Vauchier C
      – PersonEntity:
          Name:
            NameFull: Ottanelli C
      – PersonEntity:
          Name:
            NameFull: Andrade L
      – PersonEntity:
          Name:
            NameFull: Gennusa V
      – PersonEntity:
          Name:
            NameFull: Mestre RP
      – PersonEntity:
          Name:
            NameFull: Fornarini G
      – PersonEntity:
          Name:
            NameFull: Pignata S
      – PersonEntity:
          Name:
            NameFull: Procopio G
      – PersonEntity:
          Name:
            NameFull: Santini D
      – PersonEntity:
          Name:
            NameFull: Ravi P
      – PersonEntity:
          Name:
            NameFull: Sweeney C
      – PersonEntity:
          Name:
            NameFull: Heng D
      – PersonEntity:
          Name:
            NameFull: De Giorgi U
      – PersonEntity:
          Name:
            NameFull: Fizazi K
      – PersonEntity:
          Name:
            NameFull: Russo A
      – PersonEntity:
          Name:
            NameFull: Francini E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0682
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical genitourinary cancer
              Type: main
ResultId 1